Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Urologic Oncology|October 10, 2020
Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologistsBarak Rosenzweig, Axel Bex, Zohar A Dotan, et al.
Cancer|September 12, 2008
Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancerJoel B Nelson, William Love, Joseph L Chin, et al.
Urologia Internationalis|October 19, 2011
Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsyMaximilien C Goris Gbenou, Alexandre Peltier, Sanjai K Addla, et al.
The Journal of Urology|February 11, 2003
Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentanJoel B Nelson, Azmi A Nabulsi, Nicholas J Vogelzang, et al.
World Journal of Urology|April 19, 2003
Radical prostatectomy: a prospective comparison of oncological and functional results between open and laparoscopic approachesThierry Roumeguere, Renaud Bollens, Marc Vanden Bossche, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
The need to embrace molecular profiling of tumor cells in prostate and bladder cancerBrian J Duggan, John J McKnight, Kate E Williamson, et al.
European Urology|May 8, 2007
Laparoscopic partial nephrectomy with "on-demand" clamping reduces warm ischemia timeRenaud Bollens, Alberto Rosenblatt, Baldo P Espinoza, et al.
Cancer|September 22, 2007
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancerMichael A Carducci, Fred Saad, Per-Anders Abrahamsson, et al.
European Urology|May 20, 2004
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysisFrans Debruyne, Peter Boyle, Fernando Calais Da Silva, et al.
European Urology|June 9, 2004
Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patientsAlexandre R Zlotta, Thierry Roumeguère, Vincent Ravery, et al.
Pageof 4